Woodline Partners’s Amedisys AMED Stock Holding History

Woodline Partners’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-240,003	Closed	-$22M	–	598
2024 Q2	$22M	Sell	240,003 -210,000	-47%	-$19.5M	0.21%	154
2024 Q1	$41.5M	Buy	450,003 +3,310	+0.7%	+$310K	0.38%	76
2023 Q4	$42.5M	Sell	446,693 -15,613	-3%	-$1.46M	0.46%	63
2023 Q3	$43.2M	Buy	462,306 +281,404	+156%	+$26M	0.51%	41
2023 Q2	$16.5M	Buy	+180,902	New	+$14.8M	0.2%	149
2022 Q2	–	Sell	-29,878	Closed	-$5.15M	–	798
2022 Q1	$5.15M	Buy	+29,878	New	+$4.46M	0.08%	241
2021 Q2	–	Sell	-2,516	Closed	-$666K	–	590
2021 Q1	$666K	Buy	+2,516	New	+$710K	0.01%	384
2020 Q4	–	Sell	-59,504	Closed	-$14.1M	–	221
2020 Q3	$14.1M	Buy	+59,504	New	+$13.5M	0.46%	60

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Woodline Partners's AMED Position: Q3 2024 in Review

Woodline Partners sold out of Amedisys (AMED) in Q3 2024, closing a stake of 240,003 shares — an estimated $22M sold.

Woodline Partners first reported a position in AMED in Q3 2020 and held it in 8 quarters. The position peaked at $43.2M in Q3 2023. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

Woodline Partners reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
Woodline Partners sold 240,003 Amedisys shares in Q3 2024, an estimated $22M.
Woodline Partners first reported a position in Amedisys in Q3 2020 and held it in 8 quarters.
Woodline Partners's Amedisys position peaked at $43.2M in Q3 2023.
285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.